(Q36454256)

14 August 2017

1 reference

title

Spectrum of activity of azithromycin (English)

1 reference

14 August 2017

0 references

Williams JD

1

1 reference

14 August 2017

1 October 1991

1 reference

European Journal of Clinical Microbiology & Infectious Diseases

14 August 2017

1 reference

14 August 2017

10

1 reference

14 August 2017

10

1 reference

14 August 2017

813-820

1 reference

https://scigraph.springernature.com/pub.10.1007/bf01975833

14 August 2017

0 references

cites work

Comparative in vitro activities of new 14-, 15-, and 16-membered macrolides

1 reference

https://api.crossref.org/works/10.1007%2FBF01975833

Comparative in-vitro activity of azithromycin and erythromycin against Gram-positive cocci, Haemophilus influenzae and anaerobes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01975833

Spectrum and mode of action of azithromycin (CP-62,993), a new 15-membered-ring macrolide with improved potency against gram-negative organisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01975833

In-vitro activity of azithromycin, erythromycin, ciprofloxacin and norfloxacin against Neisseria gonorrhoeae, Haemophilus ducreyi, and Chlamydia trachomatis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01975833

Azithromycin in the treatment of sexually transmitted disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01975833

In-vitro activity of azithromycin compared with other macrolides and oral antibiotics against Salmonella typhi.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01975833

In-vitro activity of azithromycin against various Gram-negative bacilli and anaerobic bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01975833

Bacteriostatic and bactericidal activity of azithromycin against Haemophilus influenzae

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01975833

Efficacy of azithromycin in the treatment of guinea pigs infected with Legionella pneumophila by aerosol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01975833

In vitro activity of azithromycin against clinical isolates of Legionella species

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01975833

In vitro and in vivo uptake of azithromycin (CP-62,993) by phagocytic cells: possible mechanism of delivery and release at sites of infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01975833

In vitro effects of four macrolides (roxithromycin, spiramycin, azithromycin [CP-62,993], and A-56268) on Toxoplasma gondii

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01975833

Azithromycin, a macrolide antibiotic with potent activity against Toxoplasma gondii

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01975833

In vitro and in vivo activity of azithromycin (CP 62,993) against the Mycobacterium avium complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01975833

In vitro activities of several new macrolide antibiotics against Mycobacterium avium complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01975833

In-vitro and in-vivo susceptibility of Borrelia burgdorferi to azithromycin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01975833

Comparative antimicrobial activity of the new macrolides against Borrelia burgdorferi

21 January 2018

1 reference

12 December 2020

In-vitro activity of erythromycin, roxithromycin and CP 62993 against common paediatric pathogens

1 reference

12 December 2020

The in-vitro antibiotic susceptibility of Chlamydia pneumoniae

1 reference

12 December 2020

Gynaecological tissue levels of azithromycin

1 reference

12 December 2020

In vitro comparison of the activity of doxycycline, tetracycline, erythromycin and a new macrolide, CP 62993, against Mycoplasma pneumoniae, Mycoplasma hominis and Ureaplasma urealyticum

1 reference

12 December 2020

The pharmacokinetics of azithromycin in human serum and tissues

1 reference

12 December 2020

[Clinical and pharmacologic studies conducted in Japan]

1 reference

12 December 2020

The in-vitro activity of CP-62,993 against Haemophilus influenzae, Branhamella catarrhalis, staphylococci and streptococci

1 reference

12 December 2020

Comparative in vitro activity of the new oral macrolide azithromycin

1 reference

12 December 2020

In vitro activity of azithromycin and erythromycin against organisms associated with bacterial vaginosis and chancroid

1 reference

12 December 2020

In vitro activity of azithromycin (CP-62,993), a novel macrolide, against enteric pathogens

1 reference

12 December 2020

Susceptibility of clinical isolates of Campylobacter pylori to twenty-one antimicrobial agents

1 reference

12 December 2020

Azithromycin concentrations at the sites of pulmonary infection

1 reference

12 December 2020

Susceptibility of Campylobacter pylori to macrolides and fluoroquinolones.

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01975833

1 reference

14 August 2017

1 reference

PubMed ID

1662624